These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

779 related items for PubMed ID: 23188675

  • 1. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
    Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, Lee KH, Yeh SD, Hong TM, Chen YL.
    Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
    [Abstract] [Full Text] [Related]

  • 2. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
    Cai C, Zhu X.
    Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
    [Abstract] [Full Text] [Related]

  • 3. β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway.
    Zhou AD, Diao LT, Xu H, Xiao ZD, Li JH, Zhou H, Qu LH.
    Oncogene; 2012 Jun 14; 31(24):2968-78. PubMed ID: 22020335
    [Abstract] [Full Text] [Related]

  • 4. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok MT, Wang H, Chen J, Ng SS, Chen M, Sung JJ, Yu J.
    Oncogene; 2013 Oct 17; 32(42):5078-88. PubMed ID: 23208495
    [Abstract] [Full Text] [Related]

  • 5. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D, Wang M, Guo W, Huang S, Wang Z, Zhao X, Du H, Song L, Peng X.
    Cell Tissue Res; 2014 Dec 17; 358(3):763-78. PubMed ID: 25296715
    [Abstract] [Full Text] [Related]

  • 6. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
    Ren W, Wang D, Li C, Shu T, Zhang W, Fu X.
    Biomed Pharmacother; 2018 Dec 17; 108():467-475. PubMed ID: 30241050
    [Abstract] [Full Text] [Related]

  • 7. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y, Dahiya R.
    Clin Cancer Res; 2011 Aug 15; 17(16):5287-98. PubMed ID: 21159887
    [Abstract] [Full Text] [Related]

  • 8. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
    Ge C, Wu S, Wang W, Liu Z, Zhang J, Wang Z, Li R, Zhang Z, Li Z, Dong S, Wang Y, Xue Y, Yang J, Tan Q, Wang Z, Song X.
    Oncotarget; 2015 May 10; 6(13):10964-77. PubMed ID: 25844602
    [Abstract] [Full Text] [Related]

  • 9. miR-150-5p suppresses the stem cell-like characteristics of glioma cells by targeting the Wnt/β-catenin signaling pathway.
    Tian W, Zhu W, Jiang J.
    Cell Biol Int; 2020 May 10; 44(5):1156-1167. PubMed ID: 32009256
    [Abstract] [Full Text] [Related]

  • 10. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
    Wu G, Liu A, Zhu J, Lei F, Wu S, Zhang X, Ye L, Cao L, He S.
    Oncotarget; 2015 Oct 06; 6(30):28882-94. PubMed ID: 26337084
    [Abstract] [Full Text] [Related]

  • 11. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
    Rowehl RA, Crawford H, Dufour A, Ju J, Botchkina GI.
    Cancer Genomics Proteomics; 2008 Oct 06; 5(6):301-10. PubMed ID: 19287071
    [Abstract] [Full Text] [Related]

  • 12. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.
    Liu H, Yin J, Wang H, Jiang G, Deng M, Zhang G, Bu X, Cai S, Du J, He Z.
    Cell Signal; 2015 Mar 06; 27(3):510-8. PubMed ID: 25578861
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway.
    Yu T, Liu K, Wu Y, Fan J, Chen J, Li C, Yang Q, Wang Z.
    Oncogene; 2014 Oct 16; 33(42):5017-27. PubMed ID: 24141785
    [Abstract] [Full Text] [Related]

  • 14. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway.
    Li Q, Ye L, Guo W, Wang M, Huang S, Peng X.
    J Exp Clin Cancer Res; 2017 Jun 23; 36(1):85. PubMed ID: 28645312
    [Abstract] [Full Text] [Related]

  • 15. MiR-612 suppresses the stemness of liver cancer via Wnt/β-catenin signaling.
    Tang J, Tao ZH, Wen D, Wan JL, Liu DL, Zhang S, Cui JF, Sun HC, Wang L, Zhou J, Fan J, Wu WZ.
    Biochem Biophys Res Commun; 2014 Apr 25; 447(1):210-5. PubMed ID: 24704424
    [Abstract] [Full Text] [Related]

  • 16. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
    Schepeler T, Holm A, Halvey P, Nordentoft I, Lamy P, Riising EM, Christensen LL, Thorsen K, Liebler DC, Helin K, Ørntoft TF, Andersen CL.
    Oncogene; 2012 May 31; 31(22):2750-60. PubMed ID: 21963845
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.
    Xu J, Zhu X, Wu L, Yang R, Yang Z, Wang Q, Wu F.
    Liver Int; 2012 May 31; 32(5):752-60. PubMed ID: 22276989
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
    Chang YL, Zhou PJ, Wei L, Li W, Ji Z, Fang YX, Gao WQ.
    Oncotarget; 2015 Sep 15; 6(27):24017-31. PubMed ID: 26172296
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-1297 inhibits prostate cancer cell proliferation and invasion by targeting the AEG-1/Wnt signaling pathway.
    Liang X, Li H, Fu D, Chong T, Wang Z, Li Z.
    Biochem Biophys Res Commun; 2016 Nov 11; 480(2):208-214. PubMed ID: 27746178
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling.
    Guan H, Liu C, Fang F, Huang Y, Tao T, Ling Z, You Z, Han X, Chen S, Xu B, Chen M.
    Oncotarget; 2017 Feb 28; 8(9):14693-14707. PubMed ID: 28107193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.